NATtrol Respiratory Syncytial Virus Type A Stock (NATRSVA-ST) is formulated with purified, intact virus particles that have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of RSV A NATtrol. NATRSVA-ST stock is supplied in a purified protein matrix that mimics the composition of a true clinical specimen.

NATtrol Respiratory Syncytial Virus Type A Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of RSVA RNA. NATRSVA-ST can also be used for validation of clinical assays, development of diagnostic tests and training of laboratory personnel. NATRSVA-ST contains intact virus and should be run in a manner identical to that used for clinical specimens.

Qualitative – Real-Time PCR / +2? to +8? C.
Product Insert.pdf

Material Safety Data Sheet.pdf